↓ Skip to main content

Dove Medical Press

Article Metrics

Modulation of neurotrophic signaling pathways by polyphenols

Overview of attention for article published in Drug Design, Development and Therapy, December 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#49 of 1,417)
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
14 tweeters
patent
1 patent
reddit
1 Redditor

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
113 Mendeley
Title
Modulation of neurotrophic signaling pathways by polyphenols
Published in
Drug Design, Development and Therapy, December 2015
DOI 10.2147/dddt.s96936
Pubmed ID
Authors

Omidreza Firuzi, Fatemeh Moosavi, Razieh Hosseini, Luciano Saso

Abstract

Polyphenols are an important class of phytochemicals, and several lines of evidence have demonstrated their beneficial effects in the context of a number of pathologies including neurodegenerative disorders such as Alzheimer's and Parkinson's disease. In this report, we review the studies on the effects of polyphenols on neuronal survival, growth, proliferation and differentiation, and the signaling pathways involved in these neurotrophic actions. Several polyphenols including flavonoids such as baicalein, daidzein, luteolin, and nobiletin as well as nonflavonoid polyphenols such as auraptene, carnosic acid, curcuminoids, and hydroxycinnamic acid derivatives including caffeic acid phentyl ester enhance neuronal survival and promote neurite outgrowth in vitro, a hallmark of neuronal differentiation. Assessment of underlying mechanisms, especially in PC12 neuronal-like cells, reveals that direct agonistic effect on tropomyosin receptor kinase (Trk) receptors, the main receptors of neurotrophic factors including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) explains the action of few polyphenols such as 7,8-dihydroxyflavone. However, several other polyphenolic compounds activate extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/Akt pathways. Increased expression of neurotrophic factors in vitro and in vivo is the mechanism of neurotrophic action of flavonoids such as scutellarin, daidzein, genistein, and fisetin, while compounds like apigenin and ferulic acid increase cyclic adenosine monophosphate response element-binding protein (CREB) phosphorylation. Finally, the antioxidant activity of polyphenols reflected in the activation of Nrf2 pathway and the consequent upregulation of detoxification enzymes such as heme oxygenase-1 as well as the contribution of these effects to the neurotrophic activity have also been discussed. In conclusion, a better understanding of the neurotrophic effects of polyphenols and the concomitant modulations of signaling pathways is useful for designing more effective agents for management of neurodegenerative diseases.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Russia 1 <1%
Poland 1 <1%
Unknown 111 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 19%
Student > Master 17 15%
Unspecified 16 14%
Student > Bachelor 13 12%
Researcher 13 12%
Other 33 29%
Readers by discipline Count As %
Unspecified 25 22%
Agricultural and Biological Sciences 21 19%
Biochemistry, Genetics and Molecular Biology 19 17%
Pharmacology, Toxicology and Pharmaceutical Science 13 12%
Medicine and Dentistry 12 11%
Other 23 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2018.
All research outputs
#1,319,039
of 13,598,490 outputs
Outputs from Drug Design, Development and Therapy
#49
of 1,417 outputs
Outputs of similar age
#40,390
of 359,603 outputs
Outputs of similar age from Drug Design, Development and Therapy
#4
of 90 outputs
Altmetric has tracked 13,598,490 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,417 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,603 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.